NSE filing, NSE: AVPINFRA. Summary written from the filing by ALFA Finder's alert engine.
AVP Infracon Ltd: key numbers
- Share price
- ₹59.60
- Market cap
- ₹175.2 Cr
- Revenue (annual)
- ₹441.4 Cr
- Net profit (annual)
- ₹42.11 Cr
- P/E (TTM)
- 4.2×Sector 32.2×
- Promoter holding
- 62.41%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AVP Infracon Ltd
All →AVP Infracon Board Meeting Date
AVP Infracon will hold a board meeting on 04 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 01 Oct to 09 Nov 2026.
AVP Infracon Business Update
AVP Infracon disclosed satisfactory H1 FY27 progress with 80% recovery of overdue receivables. H1 turnover grew approximately 25% year-on-year, signalling operational improvement.
AVP Infracon Capital Structure Change
AVP Infracon Limited has completed its QIP, allocating 44.24 lakh equity shares at Rs. 56.50 per share to Qualified Institutional Buyers.
- Value
- ₹25.00 Cr
AVP Infracon Other Announcement
AVP Infracon Limited has submitted an intimation stating that the requirement for filing a Corporate Governance Report is not applicable to the company.
AVP Infracon Annual General Meeting
AVP Infracon Limited held its 17th Annual General Meeting on September 24, 2026, where shareholders considered various ordinary and special business resolutions.
AVP Infracon Annual General Meeting
AVP Infracon Limited has issued a notice for its 17th Annual General Meeting scheduled for September 24, 2026. The meeting will address financial statements, director re-appointments, and operational approvals.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr